Literature DB >> 20180002

The ectopic F(O)F(1) ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein IF1.

Valentina Giorgio1, Elena Bisetto, Raffaella Franca, David A Harris, Sabina Passamonti, Giovanna Lippe.   

Abstract

Rat liver plasma membranes contain F(O)F(1) complexes (ecto-F(O)F(1)) displaying a similar molecular weight to the mitochondrial F(O)F(1) ATP synthase, as evidenced by Blue Native PAGE. Their ATPase activity was stably reduced in short-term extra-hepatic cholestasis. Immunoblotting and immunoprecipitation analyses demonstrated that the reduction in activity was not due to a decreased expression of ecto-F(O)F(1) complexes, but to an increased level of an inhibitory protein, ecto-IF(1), bound to ecto-F(O)F(1). Since cholestasis down regulates the hepatic uptake of HDL-cholesterol, and ecto-F(O)F(1) has been shown to mediate SR-BI-independent hepatic uptake of HDL-cholesterol, these findings provide support to the hypothesis that ecto-F(O)F(1) contributes to the fine control of reverse cholesterol transport, in parallel with SR-BI. No activity change of the mitochondrial F(O)F(1) ATP synthase (m-F(O)F(1)), or any variation of its association with m-IF(1) was observed in cholestasis, indicating that ecto-IF(1) expression level is modulated independently from that of ecto-F(O)F(1), m-IF(1) and m-F(O)F(1).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180002     DOI: 10.1007/s10863-010-9270-2

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  47 in total

1.  Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs.

Authors:  Naokatu Arakaki; Toshiyuki Kita; Hirofumi Shibata; Tomihiko Higuti
Journal:  FEBS Lett       Date:  2007-06-28       Impact factor: 4.124

Review 2.  High-density lipoprotein as a therapeutic target: a systematic review.

Authors:  Inder M Singh; Mehdi H Shishehbor; Benjamin J Ansell
Journal:  JAMA       Date:  2007-08-15       Impact factor: 56.272

Review 3.  Interactions between the endoplasmic reticulum, mitochondria, plasma membrane and other subcellular organelles.

Authors:  Magdalena Lebiedzinska; György Szabadkai; Aleck W E Jones; Jerzy Duszynski; Mariusz R Wieckowski
Journal:  Int J Biochem Cell Biol       Date:  2009-03-05       Impact factor: 5.085

4.  The bioenergetic signature of cancer: a marker of tumor progression.

Authors:  José M Cuezva; Maryla Krajewska; Miguel López de Heredia; Stanislaw Krajewski; Gema Santamaría; Hoguen Kim; Juan M Zapata; Hiroyuki Marusawa; Margarita Chamorro; John C Reed
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

5.  Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.

Authors:  Thierry Claudel; Ekkehard Sturm; Hélène Duez; Inés Pineda Torra; Audrey Sirvent; Vladimir Kosykh; Jean-Charles Fruchart; Jean Dallongeville; Dean W Hum; Folkert Kuipers; Bart Staels
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

6.  Overexpression of the inhibitor protein IF(1) in AS-30D hepatoma produces a higher association with mitochondrial F(1)F(0) ATP synthase compared to normal rat liver: functional and cross-linking studies.

Authors:  Concepción Bravo; Fernando Minauro-Sanmiguel; Edgar Morales-Ríos; José S Rodríguez-Zavala; José J García
Journal:  J Bioenerg Biomembr       Date:  2004-06       Impact factor: 2.945

7.  Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse.

Authors:  Ignacio Bravo; Ludwig Amigo; David E Cohen; Flavio Nervi; Attilio Rigotti; Omar Francone; Silvana Zanlungo
Journal:  Biochim Biophys Acta       Date:  2007-03-01

8.  Lipids and risk of coronary heart disease. The Framingham Study.

Authors:  W P Castelli; K Anderson; P W Wilson; D Levy
Journal:  Ann Epidemiol       Date:  1992 Jan-Mar       Impact factor: 3.797

9.  Identification of the subunits of F1F0-ATPase from bovine heart mitochondria.

Authors:  J E Walker; R Lutter; A Dupuis; M J Runswick
Journal:  Biochemistry       Date:  1991-06-04       Impact factor: 3.162

10.  Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin.

Authors:  T L Moser; D J Kenan; T A Ashley; J A Roy; M D Goodman; U K Misra; D J Cheek; S V Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

View more
  12 in total

1.  Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Authors:  S Cumero; F Fogolari; R Domenis; R Zucchi; I Mavelli; S Contessi
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  Ectopic F0F 1 ATP synthase contains both nuclear and mitochondrially-encoded subunits.

Authors:  Amit Kumar Rai; Barbara Spolaore; David A Harris; Federica Dabbeni-Sala; Giovanna Lippe
Journal:  J Bioenerg Biomembr       Date:  2013-08-13       Impact factor: 2.945

3.  Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study.

Authors:  Annelise Genoux; Jean-Bernard Ruidavets; Jean Ferrières; Guillaume Combes; Laeticia Lichtenstein; Véronique Pons; Muriel Laffargue; Dorota Taraszkiewicz; Didier Carrié; Meyer Elbaz; Bertrand Perret; Laurent O Martinez
Journal:  J Lipid Res       Date:  2013-06-21       Impact factor: 5.922

Review 4.  ATP Secretion and Metabolism in Regulating Pancreatic Beta Cell Functions and Hepatic Glycolipid Metabolism.

Authors:  Jing Li; Han Yan; Rui Xiang; Weili Yang; Jingjing Ye; Ruili Yin; Jichun Yang; Yujing Chi
Journal:  Front Physiol       Date:  2022-06-21       Impact factor: 4.755

5.  Mitochondrial inhibitory factor 1 (IF1) is present in human serum and is positively correlated with HDL-cholesterol.

Authors:  Annelise Genoux; Véronique Pons; Claudia Radojkovic; Florence Roux-Dalvai; Guillaume Combes; Corinne Rolland; Nicole Malet; Bernard Monsarrat; Frédéric Lopez; Jean-Bernard Ruidavets; Bertrand Perret; Laurent O Martinez
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

6.  Mitochondrial GWA Analysis of Lipid Profile Identifies Genetic Variants to Be Associated with HDL Cholesterol and Triglyceride Levels.

Authors:  Antònia Flaquer; Susanne Rospleszcz; Eva Reischl; Sonja Zeilinger; Holger Prokisch; Thomas Meitinger; Christa Meisinger; Annette Peters; Melanie Waldenberger; Harald Grallert; Konstantin Strauch
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

7.  IF1, a natural inhibitor of mitochondrial ATP synthase, is not essential for the normal growth and breeding of mice.

Authors:  Junji Nakamura; Makoto Fujikawa; Masasuke Yoshida
Journal:  Biosci Rep       Date:  2013-09-17       Impact factor: 3.840

8.  Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study.

Authors:  Annelise Genoux; Laeticia Lichtenstein; Jean Ferrières; Thibaut Duparc; Vanina Bongard; Paul-Louis Vervueren; Guillaume Combes; Dorota Taraszkiewicz; Meyer Elbaz; Michel Galinier; Bertrand Nassar; Jean-Bernard Ruidavets; Bertrand Perret; Laurent O Martinez
Journal:  BMC Med       Date:  2016-08-23       Impact factor: 8.775

9.  Kinetic analysis of ATP hydrolysis by complex V in four murine tissues: Towards an assay suitable for clinical diagnosis.

Authors:  Francis Haraux; Anne Lombès
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240

10.  Analysis of the clinical relevance of antimitochondrial antibodies to the β- and γ-subunits of the F1F0-ATPase in patients with primary biliary cirrhosis.

Authors:  Dominik Nann; Christoph P Berg; Beate E Preuss; Reinhild Klein
Journal:  BMC Gastroenterol       Date:  2012-10-24       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.